Peak Frameworks

AUGUST 15, 2023

If you're interested in breaking into finance, check out our Private Equity Course and Investment Banking Course , which help thousands of candidates land top jobs every year. As of 2021, Berkshire Hathaway was Apple’s second-largest shareholder, owning approximately 5.4% of Apple’s outstanding shares.

Shares 52

Shares Financial Statement Stock Corporation 52

Peak Frameworks

SEPTEMBER 18, 2023

Consider a pharmaceutical giant like Pfizer , which imports raw materials for its drugs. If you're interested in breaking into finance, check out our , Private Equity Course and , Investment Banking Course , which help thousands of candidates land top jobs every year.

Private Equity 52

Private Equity Negotiation Transportation Valuation 52

Mergers and Inquisitions

NOVEMBER 1, 2023

For more on this, please see our healthcare investment banking article. In terms of mobility , you could easily join a healthcare investment banking team , move to a portfolio company in a corporate development role, or potentially even move into venture capital if you’ve had some life sciences exposure. in biology.

Private Equity 59

Private Equity Healthcare Equities Middle Market 59

Peak Frameworks

SEPTEMBER 19, 2023

For example, while a pharmaceutical company focused solely on shareholder value might prioritize high-margin drugs for rare conditions, a stakeholder-oriented approach might consider affordability and broader societal health needs , as seen with Gilead's approach to its HIV medications.

Corporation 52

Corporation Private Equity Mergers and Acquisitions Corporate Finance 52

Focus Investment Banking

JULY 8, 2024

He was the guy who took over a small company, Turing Pharmaceuticals, and raised the price of the life-saving drug, Daraprim, from $13.50 Do you remember hearing about Martin Shkreli, also known as “The Pharma Bro?” per pill to $750 a pill. million in personal assets.

Hospitality 40

Hospitality Entertainment Investment Pharmaceutical 40

Focus Investment Banking

DECEMBER 20, 2024

Cencora, one of the largest publicly-traded pharmaceutical companies in the world, distributes pharmaceuticals, over-the-counter healthcare products and other healthcare supplies and equipment to healthcare providers. In RCA, Cencora saw the opportunity to acquire additional profitability downstream of its existing operations.

Private Equity 52

Private Equity Healthcare Equities Sale 52

Focus Investment Banking

FEBRUARY 11, 2025

McKesson is primarily a distributor, meaning that it sells pharmaceuticals, medical supplies, and other medical devices and services to healthcare providers. These converging factors suggest a strategic opportunity for independent ophthalmology groups to contemplate a sale, and FOCUS Investment Banking stands ready to assist.

Private Equity 52

Private Equity Healthcare Equities Medical 52

Focus Investment Banking

FEBRUARY 17, 2025

Infusion Pharmacy Pharmaceutical innovations have produced an increasing number of highly specialized drug products and treatment programs, which may be customized even to the patient level. These drugs are also increasingly delivered via infusion, and investors are taking notice.

Private Equity 52

Private Equity Healthcare Equities Investors 52

Focus Investment Banking

MAY 14, 2025

While much of the discussion has centered on the effects of his tariffs, the administrations promise of business-friendly policies and tax incentives are already yielding significant new investments in US manufacturing. These long-term investments mark a new era of production for many companies.

Manufacturing 52

Manufacturing M&A Middle Market Trading 52

Mergers and Inquisitions

MARCH 19, 2025

We covered these points and the main verticals in the consumer retail investment banking article. Matt Stoller has an excellent article summing up the companys problems , but the short version is that it came under severe margin pressure due to pharmaceutical pricing : Health insurance companies in the U.S.

Private Equity 59

Private Equity Retail Equities Mergers and Acquisitions 59

MergersCorp M&A International

NOVEMBER 16, 2024

as a favorable destination for investment. firms, particularly in technology and pharmaceuticals, sectors that are considered critical to America’s future economic competitiveness. This influx of foreign investments often led to high-profile acquisitions, creating a vibrant M&A scene.

Mergers and Acquisitions 52

Mergers and Acquisitions Mergers Acquisitions M&A 52